Men's Health News

RSS

Curcumin can inhibit formation of prostate cancer metastases

Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universit-t (LMU) in Munich now shows that it can also inhibit formation of metastases.

13 Oct 2012

Sun protection: an interview with Jane Hanrahan

UV radiation is a form of energy being transmitted. Sunlight is main source of UV radiation, although manmade sources also exist, such as the lamps used in sunbeds. At the earth’s surface sunlight consists of approximately 2 percent UV light, 47 percent visible light and 51 percent IR light.

11 Oct 2012

Women respond much better than men to treatment of CFL with rituximab

Women respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of a multi-centre, Austria-wide study by the Arbeitsgemeinschaft medikamentöse Tumortherapie (AGMT) carried out under the supervision of the University Department of Internal Medicine I and study leader Ulrich Jäger, which has now been published in the highly respected journal "Haematologica".

11 Oct 2012

Six-gene signature can predict survival in men with aggressive prostate cancer

Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.

11 Oct 2012

Testosterone fosters social behavior in men

The hormone testosterone stands for typically male attributes - it fosters the forming of the sexual characteristics, increases libido and muscle building. Women also have this sex hormone, but to a much lesser extent.

11 Oct 2012

UCSF project to explore mystery behind advanced prostate cancer

Many men survive prostate cancer, but thousands of others -- whose cancer spreads -- inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.

10 Oct 2012

PARP-1 plays a major role in controlling AR function in prostate cancer patients

A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests.

10 Oct 2012

NIH-funded study to examine factors behind alcohol-related violence within intimate relationships

Georgia State University's Dominic Parrott and Christopher Eckhardt at Purdue University in Indiana have received a five-year, $2.6 million grant from the National Institutes of Health to examine the underlying factors behind alcohol intoxication and violence between significant others and spouses.

10 Oct 2012

Study examines trends in HIV mortality

Overall death rates due to human immunodeficiency virus (HIV) infection declined over time between 1993 and 2007 for most men and women by race/ethnicity and educational levels, with the largest absolute decreases for nonwhites, but rates remain high among blacks, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

9 Oct 2012

Study determines impact of HIV on anal cancer incidence in the U.S.

The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute.

8 Oct 2012

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Gender-specific group therapy is effective for treating depressed women with Type 2 diabetes, according to a study published in the latest issue of the Annals of Behavioral Medicine and funded by the National Institute of Nursing Research.

4 Oct 2012

Study finds significant variation in overall health of all major Latino subgroups in the U.S.

Despite a shared Latino heritage, there are significant differences in the overall health and the use of health-care services among Cuban-Americans, Mexican-Americans and Puerto Rican-Americans - even between men and women in the same subgroup - according to two recently published studies by Florida State University researchers.

4 Oct 2012

‘Hygiene hypothesis’ updated to ‘Old Friends’ hypothesis

A new scientific report out today from the International Scientific Forum on Home Hygiene (IFH) dismantles the myth that the epidemic rise in allergies in recent years has happened because we’re living in sterile homes and overdoing hygiene.

3 Oct 2012

Ranibizumab injections keep those with AMD driving longer

The advanced neovascular, or “wet,” form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But results of a new study, published in the online version of the journal Ophthalmology, suggest that monthly injections of ranibizumab improve eye chart test results required for a driver’s license, build driver confidence and keep those with AMD driving longer.

3 Oct 2012

Low serum levels of IGF-1 and IGFBP-3 associated with Alzheimer's in men

Low serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) are associated with Alzheimer's Disease in men, but not women, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

3 Oct 2012

ASTRO selects Boston-area resident as 2012 Survivor Circle Award winner

The American Society for Radiation Oncology (ASTRO) has selected Boston-area resident and prostate cancer survivor Emanuel "Manny" Hamelburg as its 2012 Survivor Circle Award winner.

3 Oct 2012

Self-harming and premature death: an interview with Prof Keith Hawton, University of Oxford Centre for Suicide Research

“Self-harm” is the term used in the UK, much of Europe and elsewhere, to describe intentional self-poisoning or self-injury. Thus it includes overdoses, attempted hanging, self-cutting etc.

2 Oct 2012

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Active Biotech and Ipsen have presented a new set of data on biomarkers from the previously concluded tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific congress ESMO (European Society for Medical Oncology) held in Vienna September 28-October 2.

1 Oct 2012

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelixis, Inc. today announced interim data from 51 patients with metastatic castration-resistant prostate cancer (CRPC) and bone metastases receiving a 40 mg daily dose of cabozantinib in an ongoing non-randomized expansion (NRE) cohort of a phase 2 randomized discontinuation trial.

1 Oct 2012

September issue of JNCCN publishes two prostate cancer articles

Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN - The Journal of the National Comprehensive Cancer Network. The articles review and clarify recent updates made to the National Comprehensive Cancer Network's (NCCN) guidelines for the screening and treatment of prostate cancer.

29 Sep 2012

Men's Health News

Curcumin can inhibit formation of prostate cancer metastases

Sun protection: an interview with Jane Hanrahan

Women respond much better than men to treatment of CFL with rituximab

Six-gene signature can predict survival in men with aggressive prostate cancer

Testosterone fosters social behavior in men

UCSF project to explore mystery behind advanced prostate cancer

PARP-1 plays a major role in controlling AR function in prostate cancer patients

NIH-funded study to examine factors behind alcohol-related violence within intimate relationships

Study examines trends in HIV mortality

Study determines impact of HIV on anal cancer incidence in the U.S.

Gender-specific group therapy effective in treating depressed women with Type 2 diabetes

Study finds significant variation in overall health of all major Latino subgroups in the U.S.

‘Hygiene hypothesis’ updated to ‘Old Friends’ hypothesis

Ranibizumab injections keep those with AMD driving longer

Low serum levels of IGF-1 and IGFBP-3 associated with Alzheimer's in men

ASTRO selects Boston-area resident as 2012 Survivor Circle Award winner

Self-harming and premature death: an interview with Prof Keith Hawton, University of Oxford Centre for Suicide Research

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

September issue of JNCCN publishes two prostate cancer articles

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News